Martín Liberal, J. J., Jungels, C., Martin-Romano, P., Rodon Ahnert, J., Aftimos, P., & Hollebecque, A. (2020). First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.

Martín Liberal, Juan Jesús, Christiane Jungels, Patricia Martin-Romano, Jordi Rodon Ahnert, Philippe Aftimos, e Antoine Hollebecque. First-in-human, Dose-escalation, Phase 1 Study of Anti-angiopoietin-2 LY3127804 As Monotherapy and in Combination With Ramucirumab in Patients With Advanced Solid Tumours. 2020.

Martín Liberal, Juan Jesús, et al. First-in-human, Dose-escalation, Phase 1 Study of Anti-angiopoietin-2 LY3127804 As Monotherapy and in Combination With Ramucirumab in Patients With Advanced Solid Tumours. 2020.